Work

Everolimus and letrozole prolongs progression-free survival in relapsed estrogen receptor–positive ovarian cancer: Preliminary results of a phase 2 clinical trial

Year: 2016

Type: article

Study design: Clinical Trial

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2016.04.389

Authors: G. Colon-Otero, N.R. Foster, S.J. Weroha, P. Haluska, T.A. Dinh, M.W. Robertson, J.A. Copland

Institutions: Mayo Clinic in Florida, Mayo Clinic

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2487541102

FWCI:

Cites:

Cited by:

Related to: 10